Tue, October 27, 2020
Mon, October 26, 2020
Fri, October 23, 2020
Thu, October 22, 2020
Wed, October 21, 2020
Tue, October 20, 2020
Mon, October 19, 2020

Matt Miksic Maintained (ABT) at Buy with Decreased Target to $118 on, Oct 22nd, 2020


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-decreased-target-to-118-on-oct-22nd-2020.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Matt Miksic of Credit Suisse, Maintained "Abbott Laboratories" (ABT) at Buy with Decreased Target from $136 to $118 on, Oct 22nd, 2020.

Matt has made no other calls on ABT in the last 4 months.



There are 8 other peers that have a rating on ABT. Out of the 8 peers that are also analyzing ABT, 0 agree with Matt's Rating of Hold.



These are the ratings of the 8 analyists that currently disagree with Matt


  • Rick Wise of "Stifel" Maintained at Strong Buy with Increased Target to $120 on, Wednesday, October 21st, 2020
  • Joshua Jennings of "TD Cowen" Maintained at Buy with Decreased Target to $113 on, Monday, October 19th, 2020
  • Robbie Marcus of "JP Morgan" Maintained at Buy with Increased Target to $125 on, Friday, October 9th, 2020
  • Mike Polark of "Wolfe Research" Initiated at Buy and Held Target at $124 on, Friday, September 11th, 2020
  • Joanne Wuensch of "Citigroup" Maintained at Strong Buy with Increased Target to $130 on, Friday, August 28th, 2020
  • Larry Biegelsen of "Wells Fargo" Maintained at Buy with Increased Target to $115 on, Thursday, August 27th, 2020
  • David Toung of "Argus Research" Maintained at Strong Buy with Increased Target to $125 on, Thursday, July 23rd, 2020
  • John Sourbeer of "UBS" Maintained at Strong Buy with Increased Target to $110 on, Friday, July 17th, 2020

Publication Contributing Sources